Division of Acquired Immunodeficiency Syndrome (DAIDS)

HIV/AIDS Network Clinical Trials Units (CTU) and Clinical Research Sites (CRS) 

As of April 18, 2007

NIAID has funded the following Clinical Trials Units (CTU) and their associated Clinical Research Sites (CRS) to implement the clinical research plans of one or more of the six NIAID-funded HIV/AIDS Clinical Trials Networks (see listing to the right).

The HIV/AIDS Clinical Trials Networks and their CTU/CRS will pursue clinical trials to address the highest priorities in HIV/AIDS research, including: (1) vaccine research and development; (2) translational research/drug development; (3) optimization of clinical management, including co-morbidities; (4) microbicides; (5) prevention of mother-to-child transmission of HIV; and (6) prevention of HIV infection.

The lists below are not final and will be updated regularly. For that reason, we encourage you to check back frequently. We will indicate when the CTU/CRS list becomes final.

Clinical Trials Units and Clinical Research Sites Listing (as of April 18, 2007):

• CTU and CRS by Institution (PDF)
• CTU and CRS by Country (PDF) 
• Domestic CTU and CRS by State (PDF) 
• CTU and CRS by Network 
• ACTG (PDF)
• HVTN (PDF)
• HPTN (PDF)
• IMPAACT (PDF)
• MTN (PDF)
• INSIGHT (PDF)

back to top